Commonwealth Equity Services
MTNB icon

Commonwealth Equity Services’s Matinas BioPharma MTNB Stock Holding History

Commonwealth Equity Services’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-966
Closed -$8K – 4151
2024
Q2 		$8K Sell
966
-20
-2% -$181 ﹤0.01% 4008
2024
Q1 		$13K Sell
986
-20
-2% -$238 ﹤0.01% 3979
2023
Q4 		$11K Buy
1,006
+20
+2% +$226 ﹤0.01% 3855
2023
Q3 		$6K Hold
986
– – ﹤0.01% 3798
2023
Q2 		$18K Buy
986
+401
+69% +$9.35K ﹤0.01% 3756
2023
Q1 		$13 Hold
585
– – ﹤0.01% 3703
2022
Q4 		$14K Hold
585
– – ﹤0.01% 3623
2022
Q3 		$18K Hold
585
– – ﹤0.01% 3589
2022
Q2 		$23K Buy
585
+5
+0.9% +$191 ﹤0.01% 3561
2022
Q1 		$23K Hold
580
– – ﹤0.01% 3648
2021
Q4 		$29K Sell
580
-468
-45% -$25K ﹤0.01% 3576
2021
Q3 		$68K Buy
1,048
+318
+44% +$13.7K ﹤0.01% 3470
2021
Q2 		$28K Hold
730
– – ﹤0.01% 3490
2021
Q1 		$38K Buy
730
+150
+26% +$10.1K ﹤0.01% 3351
2020
Q4 		$39K Buy
580
+40
+7% +$1.85K ﹤0.01% 3146
2020
Q3 		$20K Hold
540
– – ﹤0.01% 3013
2020
Q2 		$20K Hold
540
– – ﹤0.01% 2911
2020
Q1 		$16K Buy
540
+180
+50% +$10.9K ﹤0.01% 2771
2019
Q4 		$40K Buy
360
+20
+6% +$1.16K ﹤0.01% 2817
2019
Q3 		$10K Hold
340
– – ﹤0.01% 2817
2019
Q2 		$14K Buy
340
+16
+5% +$769 ﹤0.01% 2753
2019
Q1 		$17K Buy
324
+120
+59% +$6.46K ﹤0.01% 2711
2018
Q4 		$6K Hold
204
– – ﹤0.01% 2664
2018
Q3 		$9K Hold
204
– – ﹤0.01% 2777
2018
Q2 		$4K Hold
204
– – ﹤0.01% 2762
2018
Q1 		$7K Hold
204
– – ﹤0.01% 2704
2017
Q4 		$12K Hold
204
– – ﹤0.01% 2661
2017
Q3 		$13K Hold
204
– – ﹤0.01% 2543
2017
Q2 		$17K Buy
+204
New +$27.4K ﹤0.01% 2490

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Commonwealth Equity Services's MTNB Position: Q3 2024 in Review

Commonwealth Equity Services sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 966 shares — an estimated $8K sold.

Commonwealth Equity Services first reported a position in MTNB in Q2 2017 and held it in 29 quarters. The position peaked at $68K in Q3 2021. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

  • Commonwealth Equity Services reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 966 Matinas BioPharma shares in Q3 2024, an estimated $8K.
  • Commonwealth Equity Services first reported a position in Matinas BioPharma in Q2 2017 and held it in 29 quarters.
  • Commonwealth Equity Services's Matinas BioPharma position peaked at $68K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.